Below is an outline of the regulatory appraisal process of Spinraza in England and Wales.
A new Standard of Care in spinal muscular atrophy has been published.
TreatSMA has some exciting news to share about the new experimental drug being developed by Roche.
The Swiss Office for Social Security announced today that Spinraza will be funded across all types of spinal muscular atrophy in Switzerland.
Portuguese national health service has decided to offer Spinraza treatment.